An investigation into the safety, tolerability, and efficacy of high dose rivastigmine treatment in Alzheimer's disease.

被引：0
|
作者：
Shua-Haim, JR
Pass, MD
Smith, J
Lee, PP
Patel, S
机构：
[1] Jersey Shore Univ, Med Ctr, Mid Atlantic Geriatr Fellowship Program, Neptune, NJ USA
[2] Mid Atlantic Geriatr Assoc, Ocean, NJ USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2004年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
P223
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [1] An investigation into the safety, tolerability, and efficacy of high dose rivastigmine treatment in Alzheimer's disease
    Shua-Haim, JR
    Pass, MD
    Patel, S
    Lee, P
    Patel, P
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S196 - S196
  • [2] An investigation into the safety, tolerability, and efficacy of high dose rivastigmine treatment for treatment of Alzheimer's disease
    Shua-Haim, JR
    Pass, M
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 356 - 356
  • [3] Safety, tolerability and clinical impression of high dose rivastigmine treatment for patients with Alzheimer's disease (AD)
    Shua-Haim, J
    Patel, S
    Smith, J
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 232 - 233
  • [4] Investigation of safety, tolerability, and efficacy of high dose (15-17.5 mg/day) rivastigmine (exelon) treatment for Alzheimer's disease patients.
    Pass, M
    Shua-Haim, J
    Patel, S
    [J]. GERONTOLOGIST, 2003, 43 : 165 - 165
  • [5] Rivastigmine and Concomitant Memantine in Alzheimer's Disease: Safety and Tolerability
    Safirstein, Beth
    Meng, Xiangyi
    Olin, Jason T.
    [J]. CNS SPECTRUMS, 2010, 15 (09) : 594 - 598
  • [6] Safety and tolerability of high dose donepezil in patients with Alzheimer's disease. A preliminary report of a pilot study
    Pass, MD
    Shua-Haim, JR
    Patel, S
    Patel, S
    Lee, P
    Patel, P
    Smith, J
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S193 - S193
  • [7] Safety, tolerability, and caregiver's impressions of combination therapy with rivastigmine and memantine for the treatment of Alzheimer's disease
    Shua-Haim, JR
    Pass, MD
    Patel, S
    Patel, S
    Lee, P
    Smith, J
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S205 - S205
  • [8] Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia
    Darreh-Shori, Taher
    Jelic, Vesna
    [J]. EXPERT OPINION ON DRUG SAFETY, 2010, 9 (01) : 167 - 176
  • [9] Safety and tolerability of high dose donepezil in patients with Alzheimer's disease. A preliminary report of a pilot study.
    Shua-Haim, J
    Patel, S
    Patel, P
    Lee, P
    Pass, M
    Patel, S
    [J]. GERONTOLOGIST, 2004, 44 : 655 - 655
  • [10] Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer's disease in daily practice
    Seibert, Johannes
    Tracik, Ferenc
    Articus, Konstantin
    Spittler, Stefan
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012, 8 : 141 - 147
12345